University of New Mexico life sciences spin-out Tyrosine Pharma announces name change to Zocere.
Tyrosine Pharma, a spin-out of the University of New Mexico focused on developing stroke therapies, has announced a name change. Now known as Zocere, the Albuquerque-based firm said the name change better reflected its development of drugs to combat stroke and other neurological conditions. Zocere raised $250,000 in seed backing last year from angel investment…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
